The information on this site is intended for healthcare professionals. Patients should consult with their healthcare professional providers regarding their specific medical conditions and treatments as well as the information provided on this site, including the risks and benefits of certain products and services that may be discussed on this site.
By clicking "Accept", I confirm I am a healthcare professional.
V.A.C. VERAFLO™ Therapy is the only NPWT system with an instillation feature and specialized dressings that allow solutions to dwell in the wound for thorough contact with and cleansing of the wound bed.4
V.A.C. VERAFLO™ THERAPY MAY REDUCE THE LENGTH OF THERAPY, OR VISITS/DEBRIDEMENTS,
TIME TO FINAL SURGICAL PROCEDURE AND LENGTH OF STAY IN COMPARISON TO V.A.C.® THERAPY.1
An independent, retrospective study conducted at MedStar Georgetown University Hospital evaluated the impact of V.A.C. VERAFLO™ Therapy with PRONTOSAN® Wound Irrigation Solution (PHMB/Betaine) initiated at initial debridement compared to V.A.C.® Therapy.
LENGTH OF STAY
Reduction (14.9 vs 11.4 days)
p=0.034
OR VISITS
Reduction (3.0 vs 2.6 visits)
p=0.003
TIME TO FINAL SURGICAL PROCEDURE
Reduction (9.2 vs 7.5 days)
p=0.002
6-minute dwell time2
AN EFFECTIVE, EFFICIENT WAY TO HELP PREPARE THE WOUND FOR CLOSURE2, 3
A.
Helps solubilize, soften and loosen infectious materials and wound debris through-out entire wound including tunnels and undermining*
B.
Delivers topical wound solutions to help dilute infectious material and reduce bacterial population2,4
C.
Removes solubilized wound debris and infectious material including planktonic bacteria known to form biofilm5
D.
Promotes granulation tissue formation and perfusion to prepare the wound for closure
*Contact your KCI representative for a list of topical wound solutions compatible with VAC Therapy and Veraflo dressings. Prior to use, review and follow the Safety Information provided with the VAC Veraflo dressings and VAC Therapy unit. Prior to fluid instillation, review the Instructions for Use and follow the recommendations provided by the manufacturer of the desired topical wound solution.
V.A.C. VERAFLO CLEANSE CHOICE™ DRESSINGS CAN FACILITATE THE FOLLOWING
WITH REGARDS TO THICK WOUND EXUDATES SUCH AS INFECTIOUS MATERIALS (AS SLOUGH OR FIBRIN):4
Now you have another choice for complex wounds that require cleansing or more than one debridement, such as trauma wounds and pressure ulcers. And with the new larger-sized V.A.C. VERAFLO CLEANSE CHOICE™ Dressing, you have more options when treating larger wounds.
The V.A.C. VERAFLO CLEANSE CHOICE™ Dressing is comprised of a
unique 3-layer design which in conjunction with V.A.C. VERAFLO™ Therapy helps:1
Sign up for your free V.A.C. VERAFLO CLEANSE CHOICE™ Dressing product demonstration with one of our KCI representatives today
References: 1. Kim PJ, Attinger CE, Steinberg JS, et al. The impact of negative pressure wound therapy with instillation compared with standard negative-pressure wound therapy: a retrospective, historical, cohort, controlled study. Plast Reconstr Surg. 2014; 133:709-716. 2. Brinkert D, Mazon A, Naud M, et al. Negative pressure wound therapy with saline instillation: 131 case series. Int Wound J. 2013;10(Suppl 1):56-60. 3. Finkelstein EA, Corso PS, Miller TR. The Incidence and Economic Burden of Injuries in the United States. USA: Oxford University Press. 2006. 4. Teot L, Boissiere F, Fluieraru S. Novel foam dressing using negative pressure wound therapy with instillation to remove thick exudate. Int Wound J. 2017;14:842-848. 5. Gupta S, Gabriel A, Lantis J, Teot L. Clinical recommendations and practical guide for negative pressure wound therapy with instillation. Int Wound J. 2015; doi.org/10.1111/iwj.12452. 6. Kim PJ, Applewhite A, Dardano AN et al. Use of a novel foam dressing with negative pressure wound therapy and instillation: Recommendations and clinical experience. WOUNDS. 2018;30:S1-S17.
NOTE: Specific Indications, contraindications, warnings, precautions and safety information exist for KCI products and therapies. Please consult a clinician and product instructions for use prior to application. V.A.C. VERAFLO™ Therapy Dressings are a Class IIb product. Notified Body: BSI. 2797. PRA-PM-AT-00026